Treatment of indolent non-hodgkin's lymphoma with liposomal doxorubicin

被引：0
|
作者：
Ponomarova, Olga V. [1 ]
Kavetsky, R. E. [1 ]
机构：
[1] Ukrainian Acad Sci, Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [31] Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma
    van Agthoven, Michel
    Kramer, Mark H. H.
    Sonneveld, Pieter
    van der Hem, Klaas G.
    Huijgens, Peter C.
    Wijermans, Pierre W.
    Kluin-Nelemans, Hanneke C.
    Schaafsma, M. Ronald
    Biesma, Douwe H.
    Mattijssen, Vera
    Uyl-de Groot, Cain A.
    Hagenbeek, Anton
    HAEMATOLOGICA, 2005, 90 (10) : 1422 - 1432
  • [32] Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?
    Coiffier, B
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (08): : 388 - 389
  • [33] Introduction: Treatment of patients with rituximab-refractory indolent non-hodgkin's lymphoma
    Gregory, Stephanie A.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S1 - S1
  • [34] Primary lymphoma of the conjunctiva - A rare manifestation of indolent non-Hodgkin's lymphoma
    Reiser M.
    Josting A.
    Diehl V.
    Engert A.
    Annals of Hematology, 2001, 80 (5) : 311 - 313
  • [35] Primary lymphoma of the conjunctiva - a rare manifestation of indolent non-Hodgkin's lymphoma
    Reiser, M
    Josting, A
    Diehl, V
    Engert, A
    ANNALS OF HEMATOLOGY, 2001, 80 (05) : 311 - 313
  • [36] Treatment of non-Hodgkin's lymphoma
    Dranitsaris, G
    ANTI-CANCER DRUGS, 1998, 9 (10) : 879 - 888
  • [37] Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors
    Schmitt, Christian Johannes
    Dietrich, Sascha
    Ho, Antony Dick
    Witzens-Harig, Mathias
    ANNALS OF HEMATOLOGY, 2012, 91 (03) : 391 - 397
  • [38] Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors
    Christian Johannes Schmitt
    Sascha Dietrich
    Antony Dick Ho
    Mathias Witzens-Harig
    Annals of Hematology, 2012, 91 : 391 - 397
  • [39] Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma
    Newcomb, Richard A.
    Johnson, P. Connor
    Yang, Daniel
    Holmbeck, Katherine
    Choe, Joanna
    Nabily, Anisa
    Lark, Porsha
    Dhawale, Tejaswini
    Amonoo, Hermioni L.
    El-Jawahri, Areej
    ONCOLOGIST, 2023, : 441 - 449
  • [40] Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma
    Friedberg, Jonathan W.
    HAEMATOLOGICA, 2008, 93 (03) : 336 - 338
12345